株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

臨床検査市場分析:製品別 (CBC、HGB/HCT、基礎的生化学検査、BUNクレアチニン検査、電解質検査、HbA1c検査、包括的生化学検査、肝臓・腎臓・脂質検査)、および2020年までのセグメント予測

Clinical Laboratory Tests Market Analysis By Product (CBC, HGB/HCT Tests, Basic Metabolic Panel, BUN Creatinine Tests, Electrolyte Testing, HbA1c Tests, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, Lipid Panel) And Segment Forecasts To 2020

発行 Grand View Research, Inc. 商品コード 342340
出版日 ページ情報 英文 99 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
臨床検査市場分析:製品別 (CBC、HGB/HCT、基礎的生化学検査、BUNクレアチニン検査、電解質検査、HbA1c検査、包括的生化学検査、肝臓・腎臓・脂質検査)、および2020年までのセグメント予測 Clinical Laboratory Tests Market Analysis By Product (CBC, HGB/HCT Tests, Basic Metabolic Panel, BUN Creatinine Tests, Electrolyte Testing, HbA1c Tests, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, Lipid Panel) And Segment Forecasts To 2020
出版日: 2015年03月01日 ページ情報: 英文 99 Pages
概要

世界の臨床検査市場は2020年までに1,488億2,000万米ドルに達し、2014年から2020年にかけCAGR6.8%で拡大すると予測されています。慢性疾患の罹患率上昇が新規検査方法の構築などが2020年までの市場拡大を牽引するとみられています。

当レポートでは、世界の臨床検査市場について分析し、検査別見通しとともに、地域別動向などをまとめています。

第1章 エグゼクティブサマリー

第2章 臨床検査業界見通し

  • 市場セグメンテーション
  • 市場規模と成長見通し
  • 市場動向
    • 促進因子
    • 阻害因子
  • 優先される主な機会
  • 業界分析:ポーターズ
  • PESTEL分析

第3章 検査別見通し

  • 全血球計算 (CBC)
  • HGB/HCT検査
  • 基礎的生化学検査
  • BUNクレアチニン検査
  • 電解質検査
  • HbA1c検査
  • 包括的生化学検査
  • 肝臓検査
  • 腎臓検査
  • 脂質検査

第4章 地域別見通し

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の諸国

第5章 競合環境

  • Siemens
  • Charles River Laboratories
  • Quest Diagnostics Inc.
  • Bioscientia Healthcare
  • Sonic Healthcare Limited
  • Abbott Laboratories
  • Bio-Reference Laboratories
  • Labco S.A.
  • Healtscope Limited
  • Spectra Laboratories
  • Laboratory corporation of America Holdings (Labcorp)
  • ARUP Laboratories
  • Genoptix Medical Laboratory
  • Qiagen
  • Clarient Inc.
  • Genzyme Corporation

図表

目次

The global market for clinical laboratory is expected to reach USD 148.82 billion by 2020, growing at an estimated CAGR of 6.8% from 2014 to 2020. Growing prevalence of chronic diseases and the development of novel laboratory testing methodologies is expected to drive the clinical laboratory tests market through to 2020. Due to the fact that results from clinical laboratory tests are the fundamental basis upon which medical practitioners and healthcare providers form their diagnosis and prognosis for the prevention and treatment for a range of diseases, clinical laboratory tests are critical to the global healthcare and medical fraternity. A growing global prevalence of medical conditions such as diabetes, obesity and other metabolic abnormalities coupled with increasing patient awareness levels is expected to boost market growth during the forecast period.

Further key findings from the study suggest:

Basic metabolic tests dominated the market in terms of market share in 2013 due to the fact that these are a panel of seven to eight tests which form the routine list of tests prescribed for almost all medical examinations.

Growing prevalence of body weight and metabolism related abnormalities and increasing disease causing lifestyle habits promoting abnormal cholesterol level related conditions are expected to help the complete lipid panels market grow at a lucrative rate during the forecast period.

Due to the growing number of diabetic patients under treatment, it is also expected that the testing volumes for HbA1c tests will experience a productive growth in demand over the coming six years owing to their fundamental application in diabetic treatment monitoring.

North America was observed to occupy the largest share of the market in 2013 and accounted for more than one third of the revenue generated in the clinical laboratory testing market. This large share can be attributed to the existence of a sophisticated healthcare framework and supportive reimbursement policy structure in the region.

The Asia Pacific region is expected to grow at a lucrative rate throughout the forecast period due the development of clinical laboratory services and testing in the region. The presence of a large gap in supply and demand for clinical laboratory testing services in the emerging economies has also encouraged a shift in focus of the market leaders from the saturated North American and European regions to the developing markets of countries such as India and China.

Key participants in the clinical laboratory tests market include Siemens Healthcare, Quest Diagnostics Inc., Sonic Healthcare Ltd., Bioscientia Healthcare, Abbott Laboratories, Charles River Laboratories, Bio-Reference Laboratories, Healthscope Limited., Labco S.A., Laboratory Corporation of America Holdings (Labcorp), ARUP Laboratories, Qiagen, Genoptix Medical Laboratory, Clarient Inc. and Genzyme Corporation.

For the purpose of this study, Grand View Research has segmented the clinical laboratory tests market on the basis of test type, laboratory type and region:

Global Clinical Laboratory Tests, Test Type Outlook (Revenue, USD Billion, 2012 - 2020)

  • Complete Blood Count Market, by Laboratory Type
    • Primary Care Clinics
    • Central Laboratories
  • HGB/HCT Tests Market, by Laboratory Type
    • Primary Care Clinics
    • Central Laboratories
  • Basic Metabolic Panel Market, by Laboratory Type
    • Primary Care Clinics
    • Central Laboratories
  • BUN Creatinine Tests Market, by Laboratory Type
    • Primary Care Clinics
    • Central Laboratories
  • Electrolytes Testing Market, by Laboratory Type
    • Primary Care Clinics
    • Central Laboratories
  • HbA1c Tests Market, by Laboratory Type
    • Primary Care Clinics
    • Central Laboratories
  • Comprehensive Metabolic Panel Market, by Laboratory Type
    • Primary Care Clinics
    • Central Laboratories
  • Liver Panel Tests Market, by Laboratory Type
    • Primary Care Clinics
    • Central Laboratories
  • Renal Panel Tests Market, by Laboratory Type
    • Primary Care Clinics
    • Central Laboratories
  • Lipid Panel Tests Market, by Laboratory Type
    • Primary Care Clinics
    • Central Laboratories

Clinical Laboratory Tests Regional Outlook (Revenue, USD Billion, 2012 - 2020)

  • North America
    • U.S. Clinical Laboratory Tests Market, by Type
    • Rest of North America Clinical Laboratory Tests Market, by Type
  • Europe
    • Germany Clinical Laboratory Tests Market, by Type
    • Rest of Europe Clinical Laboratory Tests Market, by Type
  • Asia Pacific
    • Japan Clinical Laboratory Tests Market, by Type
    • Rest of Asia Pacific Clinical Laboratory Tests Market, by Type
  • RoW
    • Brazil Clinical Laboratory Tests Market, by Type
    • Rest of the World Clinical Laboratory Tests Market, by Type

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Clinical Laboratory Tests - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Clinical Laboratory Tests Industry Outlook

  • 2.1. Market Segmentation
  • 2.2. Market Size and Growth Prospects
  • 2.3. Clinical Laboratory Tests Market Dynamics
    • 2.3.1. Market Driver Analysis
    • 2.3.2. Market Restraint Analysis
  • 2.4. Key Opportunities Prioritized
  • 2.5. Industry Analysis - Porter's
  • 2.6. Clinical Laboratory Tests Market PESTEL Analysis, 2013

Chapter 3. Clinical Laboratory Tests by Type Outlook

  • 3.1. Complete Blood Count (CBC)
    • 3.1.1. CBC Tests Market Estimates and Forecasts, by Laboratory Type, 2012 - 2020 (USD Mn)
      • 3.1.1.1. Primary Care Clinics CBC Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
      • 3.1.1.2. Central Laboratories CBC Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
  • 3.2. HGB/HCT Tests
    • 3.2.1. HGB/HCT Tests Market Estimates and Forecasts, by Laboratory Type, 2012 - 2020 (USD Mn)
      • 3.2.1.1. Primary Care Clinics HGB/HCT Tests Market Estimates and Forecasts, 2012 - 20 (USD Mn)
      • 3.2.1.2. Central Laboratories HGB/HCT Tests Market Estimates and Forecasts, 2012 - 20 (USD Mn)
  • 3.3. Basic Metabolic Panel (BMP)
    • 3.3.1. BMP Market Estimates and Forecasts, by Laboratory Type, 2012 - 2020 (USD Mn)
      • 3.3.1.1. Primary Care Clinics BMP Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
      • 3.3.1.2. Central Laboratories BMP Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
  • 3.4. BUN Creatinine Tests (BUN CT)
    • 3.4.1. BUN CT Market Estimates and Forecasts, by Laboratory Type, 2012 - 2020 (USD Mn)
      • 3.4.1.1. Primary Care Clinics BUN CT Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
      • 3.4.1.2. Central Laboratories BUN CT Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
  • 3.5. Electrolyte Testing (ET)
    • 3.5.1. ET Market Estimates and Forecasts, by Laboratory Type, 2012 - 2020 (USD Mn)
      • 3.5.1.1. Primary Care Clinics ET Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
      • 3.5.1.2. Central Laboratories ET Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
  • 3.6. HbA1c Tests
    • 3.6.1. HbA1c Tests Market Estimates and Forecasts, by Laboratory Type, 2012 - 2020 (USD Mn)
      • 3.6.1.1. Primary Care Clinics HbA1c Tests Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
      • 3.6.1.2. Central Laboratories HbA1c Tests Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
  • 3.7. Comprehensive Metabolic Panel Tests (CMPT)
    • 3.7.1. CMPT Market Estimates and Forecasts, by Laboratory Type, 2012 - 2020 (USD Mn)
      • 3.7.1.1. Primary Care Clinics CMPT Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
      • 3.7.1.2. Central Laboratories CMPT Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
  • 3.8. Liver Panel Tests (LPT)
    • 3.8.1. LPT Market Estimates and Forecasts, by Laboratory Type, 2012 - 2020 (USD Mn)
      • 3.8.1.1. Primary Care Clinics LPT Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
      • 3.8.1.2. Central Laboratories LPT Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
  • 3.9. Renal Panel Tests (RPT)
    • 3.9.1. RPT Market Estimates and Forecasts, by Laboratory Type, 2012 - 2020 (USD Mn)
      • 3.9.1.1. Primary Care Clinics RPT Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
      • 3.9.1.2. Central Laboratories RPT Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
  • 3.10. Lipid Panel Tests (LPT)
    • 3.10.1. LPT Market Estimates and Forecasts, by Laboratory Type, 2012 - 2020 (USD Mn)
      • 3.10.1.1. Primary Care Clinics LPT Market Estimates and Forecasts, 2012 - 2020 (USD Mn)
      • 3.10.1.2. Central Laboratories LPT Market Estimates and Forecasts, 2012 - 2020 (USD Mn)

Chapter 4. Clinical Laboratory Tests Regional Outlook

  • 4.1. North America
    • 4.1.1. U.S.
      • 4.1.1.1. U.S. Complete Blood Count by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.1.1.2. U.S. HGB/HCT Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.1.1.3. U.S. Basic Metabolic Panel by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.1.1.4. U.S. BUN Creatinine Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.1.1.5. U.S. Electrolytes Testing by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.1.1.6. U.S. HbA1c Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.1.1.7. U.S. Comprehensive Metabolic Panel by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.1.1.8. U.S. Liver Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.1.1.9. U.S. Renal Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.1.1.10. U.S. Lipid Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)
  • 4.2. Europe
    • 4.2.1. Germany
      • 4.2.1.1. Germany Complete Blood Count by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.2.1.2. Germany HGB/HCT Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.2.1.3. Germany Basic Metabolic Panel by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.2.1.4. Germany BUN Creatinine Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.2.1.5. Germany Electrolytes Testing by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.2.1.6. Germany HbA1c Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.2.1.7. Germany Comprehensive Metabolic Panel by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.2.1.8. Germany Liver Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.2.1.9. Germany Renal Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.2.1.10. Germany Lipid Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)
  • 4.3. Asia Pacific
    • 4.3.1. Japan
      • 4.3.1.1. Japan Complete Blood Count by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.3.1.2. Japan HGB/HCT Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.3.1.3. Japan Basic Metabolic Panel by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.3.1.4. Japan BUN Creatinine Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.3.1.5. Japan Electrolytes Testing by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.3.1.6. Japan HbA1c Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.3.1.7. Japan Comprehensive Metabolic Panel by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.3.1.8. Japan Liver Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.3.1.9. Japan Renal Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.3.1.10. Japan Lipid Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)
  • 4.4. RoW
    • 4.4.1. Brazil
      • 4.4.1.1. Brazil Complete Blood Count by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.4.1.2. Brazil HGB/HCT Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.4.1.3. Brazil Basic Metabolic Panel by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.4.1.4. Brazil BUN Creatinine Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.4.1.5. Brazil Electrolytes Testing by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.4.1.6. Brazil HbA1c Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.4.1.7. Brazil Comprehensive Metabolic Panel by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.4.1.8. Brazil Liver Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.4.1.9. Brazil Renal Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)
      • 4.4.1.10. Brazil Lipid Panel Tests by Laboratory Type, 2012 - 2020 (USD Mn)

Chapter 5. Competitive Landscape

  • 5.1. Siemens
    • 5.1.1. Company Overview
    • 5.1.2. Revenue Analysis
    • 5.1.3. Product Benchmarking
    • 5.1.4. Strategic Development
  • 5.2. Charles River Laboratories
    • 5.2.1. Company Overview
    • 5.2.2. Revenue Analysis
    • 5.2.3. Product Benchmarking
    • 5.2.4. Strategic Development
  • 5.3. Quest Diagnostics Inc.
    • 5.3.1. Company Overview
    • 5.3.2. Revenue Analysis
    • 5.3.3. Product Benchmarking
    • 5.3.4. Strategic Development
  • 5.4. Bioscientia Healthcare
    • 5.4.1. Company Overview
    • 5.4.2. Revenue Analysis
    • 5.4.3. Product Benchmarking
    • 5.4.4. Strategic Development
  • 5.5. Sonic Healthcare Limited
    • 5.5.1. Company Overview
    • 5.5.2. Revenue Analysis
    • 5.5.3. Product Benchmarking
    • 5.5.4. Strategic Development
  • 5.6. Abbott Laboratories
    • 5.6.1. Company Overview
    • 5.6.2. Revenue Analysis
    • 5.6.3. Product Benchmarking
    • 5.6.4. Strategic Development
  • 5.7. Bio-Reference Laboratories
    • 5.7.1. Company Overview
    • 5.7.2. Revenue Analysis
    • 5.7.3. Product Benchmarking
    • 5.7.4. Strategic Development
  • 5.8. Labco S.A.
    • 5.8.1. Company Overview
    • 5.8.2. Revenue Analysis
    • 5.8.3. Product Benchmarking
    • 5.8.4. Strategic Development
  • 5.9. Healtscope Limited
    • 5.9.1. Company Overview
    • 5.9.2. Revenue Analysis
    • 5.9.3. Product Benchmarking
    • 5.9.4. Strategic Development
  • 5.10. Spectra Laboratories
    • 5.10.1. Company Overview
    • 5.10.2. Revenue Analysis
    • 5.10.3. Product Benchmarking
    • 5.10.4. Strategic Development
  • 5.11. Laboratory corporation of America Holdings (Labcorp)
    • 5.11.1. Company Overview
    • 5.11.2. Revenue Analysis
    • 5.11.3. Product Benchmarking
    • 5.11.4. Strategic Development
  • 5.12. ARUP Laboratories
    • 5.12.1. Company Overview
    • 5.12.2. Revenue Analysis
    • 5.12.3. Product Benchmarking
    • 5.12.4. Strategic Development
  • 5.13. Genoptix Medical Laboratory
    • 5.13.1. Company Overview
    • 5.13.2. Revenue Analysis
    • 5.13.3. Product Benchmarking
    • 5.13.4. Strategic Development
  • 5.14. Qiagen
    • 5.14.1. Company Overview
    • 5.14.2. Revenue Analysis
    • 5.14.3. Product Benchmarking
    • 5.14.4. Strategic Development
  • 5.15. Clarient Inc.
    • 5.15.1. Company Overview
    • 5.15.2. Revenue Analysis
    • 5.15.3. Product Benchmarking
    • 5.15.4. Strategic Development
  • 5.16. Genzyme Corporation
    • 5.16.1. Company Overview
    • 5.16.2. Revenue Analysis
    • 5.16.3. Product Benchmarking
    • 5.16.4. Strategic Development

List of Tables

  • 1. Global Clinical Laboratory Tests Market - Industry Summary & Critical Success Factors (CSFs)
  • 2. Clinical Laboratory Tests - Key Market Driver Analysis
  • 3. Clinical Laboratory Tests Market - Key Market Restraint Analysis
  • 4. Global Clinical Laboratory Tests Market, by Test Type, 2012 - 2020 (USD Million)
  • 5. Complete Blood Count Market, by Laboratory Type, 2012 - 2020 (USD Million)
  • 6. HGB/HCT Tests Market, by Laboratory Type, 2012 - 2020 (USD Million)
  • 7. Basic Metabolic Panel Market, by Laboratory Type, 2012 - 2020 (USD Million)
  • 8. BUN Creatinine Tests Market, by Laboratory Type, 2012 - 2020 (USD Million)
  • 9. Electrolytes Testing Market, by Laboratory Type, 2012 - 2020 (USD Million)
  • 10. HbA1c Tests Market, by Laboratory Type, 2012 - 2020 (USD Million)
  • 11. Comprehensive Metabolic Tests Market, by Laboratory Type, 2012 - 2020 (USD Million)
  • 12. Liver Panel Tests Market, by Laboratory Type, 2012 - 2020 (USD Million)
  • 13. Renal Panel Tests Market, by Laboratory Type, 2012 - 2020 (USD Million)
  • 14. Lipid Panel Tests Market, by Laboratory Type, 2012 - 2020 (USD Million)
  • 15. Global Clinical Laboratory Tests Market, by Region, 2012 - 2020 (USD Million)
  • 16. North America Clinical Laboratory Tests Market, by Test Type, 2012 - 2020 (USD Million)
  • 17. U.S. Clinical Laboratory Tests Market, by Test Type, 2012 - 2020 (USD Million)
  • 18. Europe Clinical Laboratory Tests Market, by Test Type, 2012 - 2020 (USD Million)
  • 19. Germany Clinical Laboratory Tests Market, by Test Type, 2012 - 2020 (USD Million)
  • 20. Asia Pacific Clinical Laboratory Tests Market, by Test Type, 2012 - 2020 (USD Million)
  • 21. Japan Clinical Laboratory Tests Market, by Test Type, 2012 - 2020 (USD Million)
  • 22. RoW Clinical Laboratory Tests Market, by Test Type, 2012 - 2020 (USD Million)
  • 23. Brazil Clinical Laboratory Tests Market, by Test Type, 2012 - 2020 (USD Million)

List of Figures

  • 1. Global Clinical Laboratory Tests Market Segmentation
  • 2. Global Clinical Laboratory Tests Market Revenue, (USD Million), 2012 - 2020
  • 3. Clinical Laboratory Tests Market Dynamics
  • 4. Clinical Laboratory Tests Market - Porter's Analysis
  • 5. Key opportunities prioritized
  • 6. Clinical Laboratory Tests Market - PESTEL Analysis
  • 7. Global Clinical Laboratory Tests Market Revenue Share by Test Type, 2013 & 2020
  • 8. Global Complete Blood Count Market, 2012 - 2020 (USD Million)
  • 9. Global HGB/HCT Tests Market, 2012 - 2020 (USD Million)
  • 10. Global Basic Metabolic Panel Market, 2012 - 2020 (USD Million)
  • 11. Global BUN Creatinine Tests Market, 2012 - 2020 (USD Million)
  • 12. Global Electrolytes Testing Market, 2012 - 2020 (USD Million)
  • 13. Global HbA1c Tests Market, 2012 - 2020 (USD Million)
  • 14. Global Comprehensive Metabolic Tests Market, 2012 - 2020 (USD Million)
  • 15. Global Liver Panel Tests Market, 2012 - 2020 (USD Million)
  • 16. Global Renal Panel Tests Market, 2012 - 2020 (USD Million)
  • 17. Global Lipid Panel Tests Market, 2012 - 2020 (USD Million)
  • 18. Global Clinical Laboratory Tests Market Revenue Share by Region, 2013 & 2020
  • 19. North America Clinical Laboratory Tests Market, 2012 - 2020 (USD Million)
  • 20. Europe Clinical Laboratory Tests Market, 2012 - 2020 (USD Million)
  • 21. Asia Pacific Clinical Laboratory Tests Market, 2012 - 2020 (USD Million)
Back to Top